Replies to post #4540 on Jaguar Health Inc (JAGX)

[TJG]

Quadri Pharma is the distributor for Mytesti they signed an agreement in 2023. I would think that agreement holds true for this drug as well But it’s possible they have another distributor lined up as well

SAN FRANCISCO, CA / ACCESSWIRE / November 2, 2023 / Napo Pharmaceuticals (Napo), a Jaguar Health, Inc. (NASDAQ:JAGX) family company, today announced that it has entered a revenue sharing license and commercialization agreement (the "Agreement") with Quadri Pharmaceuticals Store LLC (Quadri Pharma) that grants Quadri Pharma exclusive promotional, commercialization, and distribution rights for the rare disease indications of microvillus inclusion disease (MVID), other congenital diarrheal disorders, and short bowel syndrome (SBS) with intestinal failure for a powder formulation of crofelemer for oral solution.

[TJG]

I just think they are under such a gun with this Price Per Share issue that they need to get this announced... and when you look at the two 8-K each coving two different Fife notes... there was a lot of lawyering going on before they could announce the restructuring... and now those are done and out... They almost have to release the Phase III results before Friday... Because even if they use the 5 pm filing time like they did with the other three 8-K filings since March 1st..... come Monday this will open at 3 cents on news of a RS.....

People need, and by people I mean Lisa and her band of morons... that this is being traded by penny stock people and they control it at the moment... you mention Reverse Split to penny stock traders and 90% of them will sell on the spot... Seems to me this is the week. Sure hope so as I would like to put all this bull shit behind us and get on with just where this can really go with this product being on the market.